Ainos, Inc. (NASDAQ:AIMD) Short Interest Update

Ainos, Inc. (NASDAQ:AIMD) saw a significant growth in short interest in March. As of March 15th, there was short interest totalling 91,100 shares, a growth of 1,098.7% from the February 29th total of 7,600 shares. Approximately 5.6% of the company’s stock are short sold. Based on an average daily volume of 1,830,000 shares, the days-to-cover ratio is currently 0.0 days.

Ainos Stock Down 3.4 %

Shares of NASDAQ:AIMD opened at $1.14 on Friday. The stock has a market cap of $6.78 million, a price-to-earnings ratio of -0.45 and a beta of 1.44. The business’s 50 day moving average is $1.10 and its 200 day moving average is $2.24. Ainos has a 12-month low of $0.79 and a 12-month high of $6.10. The company has a quick ratio of 1.72, a current ratio of 1.85 and a debt-to-equity ratio of 0.24.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.